Back to Lido Advisors, LLC Lido Advisors, LLC

CPRXCPRX
Showing 8 of 31 quarters

Position history for Lido Advisors, LLCLido Advisors, LLC's holdings in CATALYST PHARMACEUTICALS INC

Lido Advisors, LLC holds 27,098 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $851,690 as of 2026-Q2. The position was increased (+1.0% shares). CPRX represents 0.0% of Lido Advisors, LLC's portfolio.

Current Value

$851,690

Current Shares

27,098

Total Value Change

+$414,171

Total Shares Change

+5,090

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
27,098
+1.0%
$851,6900.0%$31.43
25
2026-Q1
Decreased
26,841
-5.8%
$664,5830.0%$23.92
0
2025-Q4
Unchanged
28,505
0.0%
$561,5490.0%$23.29
0
2025-Q3
Increased
28,505
+16.7%
$561,5490.0%$19.55
28
2025-Q2
Decreased
24,422
-0.8%
$529,9580.0%$21.78
0
2025-Q1
Decreased
24,612
-0.2%
$596,8420.0%$24.69
0
2024-Q4
Increased
24,658
+12.0%
$514,6120.0%$21.07
27
2024-Q3
Increased
22,008
+49.5%
$437,5190.0%$19.56
33

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used